نتائج البحث 131-140 من 2089 لعملية البحث عن anti-TNF drugs
U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/fda-releases-important-information-about-risk-covid-19-due-certain- ...
Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...
... drug therapy against pulmonary mycobacterium avium complex (MAC) disease, and whether 2-drug therapy is better tolerated than 3-drug therapy. A Study to ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
... treatment participants get is decided by chance. Semaglutide is a medicine, doctors can prescribe in some countries for the treatment of type 2 diabetes.
The drugs are Niraparib (Zejula) and Dostarlimab. ... anti-T-cell immunoglobulin and ITM domain (TIGIT) ... Giving atezolizumab with usual treatment may work better ...
... treatment, or cannot be surgically removed. Drugs such as sapanisertib may ... Anti-cancer activity will be assessed every 6 weeks during therapy and ...
... treatment until disease progression or 2 years since treatment ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... anti-PD(L)1 ...
Drugs used in chemotherapy, such as paclitaxel ... anti-HER2 therapies, such as trastuzumab ... Drugs used in chemotherapy, such as temozolomide ...
PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti ... Drugs used in chemotherapy, such as cisplatin ... treatment in patients with ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.